Weekly curation
VivaEver weekly: sleep, muscles, and Alzheimer’s research
Five readings on fluid flow in the brain during sleep, muscle repair, lifetime exposures, and Alzheimer’s research.
This week's highlights
Older adults show smaller cerebrospinal fluid waves during sleep
Original title: Waves that clear waste from the brain during sleep are impaired in older adults
What the source reports
MIT reports on a human study that used functional MRI and electroencephalography in a cross-sectional comparison of adults ages 18 to 39 and 60 to 84. During non-REM sleep, cerebrospinal fluid waves were smaller on average in the older group. Experiments while participants were awake also pointed to differences in how brain blood vessels respond.
Why it is worth following
Measuring brain activity and fluid flow at the same time helps researchers investigate how sleep and blood vessel responses relate to this flow at different ages.
Evidence context and limitations
The age group comparison and laboratory experiments do not show whether these differences predict dementia. The study did not directly measure waste removal from the brain or test treatments during sleep in older adults.
How the cells that repair muscle change with age
Original title: Satellite cell attrition and skeletal muscle aging
What the source reports
This review brings together studies on satellite cells, the stem cells that help repair skeletal muscle. The authors describe how changes within the cells, such as mitochondrial dysfunction, and in the surrounding tissue, such as persistent inflammation, may reduce the muscle’s ability to regenerate.
Why it is worth following
Studying both the cells and the surrounding tissue may help explain why muscle loses some of its ability to repair itself in older age.
Evidence context and limitations
The review draws on several kinds of evidence, including studies in animals and cells. Findings on cell therapies or gene editing do not yet establish safety or benefit for older adults with sarcopenia.
Consensus proposes measuring lifetime exposures to study aging
Original title: Understanding the exposome across the life course to promote healthy aging: consensus recommendations from the Gateway Exposome Coordinating Center
What the source reports
The Gateway Exposome Coordinating Center proposes studying together the environmental and social exposures that accumulate over a lifetime, known as the exposome. The group recommends recording when and where exposures occur and using comparable measures informed by sources such as wearable sensors and administrative records.
Why it is worth following
Comparable measures could help researchers investigate at which stages of life and in which settings exposures are associated with health in older age.
Evidence context and limitations
The consensus guides research. The article reports no new intervention results and does not estimate how much an environmental change would reduce dementia risk.
Mitochondria-derived vesicles in a model of Alzheimer’s disease
Original title: Mitochondria-derived extracellular vesicles mediate Alzheimer’s disease pathology through transmitting microglial Ggt1
What the source reports
The preclinical study found more mitochondria-derived vesicles in postmortem brain tissue from people with Alzheimer’s disease than in tissue from donors without cognitive impairment. In a mouse model of the disease, inhibiting Ggt1, a protein found in those vesicles, reduced disease-related changes.
Why it is worth following
The experiments suggest a way to investigate how substances carried between cells may contribute to brain changes in Alzheimer’s disease.
Evidence context and limitations
The human sample was small and showed only an association. The intervention was tested in experimental models and does not establish safety or benefit in people.
Alzheimer’s study will expand recruitment through a mobile clinic
Original title: $32 million NIH grant expands decades-long Alzheimer’s study
What the source reports
WashU Medicine announced five years of funding from the US National Institute on Aging to expand a longitudinal study of Alzheimer’s disease. The team plans to use a mobile clinic to recruit 300 people with different levels of education, incomes, and health histories. It will also track responses to newer treatments in routine care.
Why it is worth following
Bringing the research into neighborhoods may reduce barriers to participation and include people whose backgrounds have been underrepresented in the study.
Evidence context and limitations
The announcement describes recruitment and follow-up plans. The expansion has yet to report results on biomarker performance or the effects of the treatments being tracked.